Method for analyzing a tumor-specific marker
AssigneeSnipping GmbH
InventorNils Martin Nesheim
Life of this patent
Estimating the term…
Abstract
A method for analyzing a tumor-specific marker and to the use of an isolate from ejaculate for diagnosing and/or monitoring prostate cancer, and/or for monitoring the success of prostate cancer therapy. The method includes the steps of performing an analysis on the isolate, wherein the tumor-specific marker selected from a protein, DNA, and RNA is analyzed, wherein the isolate was obtained by fractionating ejaculate into a low-density cell population and a high-density cell population, wherein the high-density cell population including mature sperm cells was separated and the isolate includes the low-density cell population, wherein the isolate includes a cell pellet.
Claims15
A method for analyzing a tumor-specific marker, wherein the method comprises:
- performing an analysis on an isolate, wherein the tumor-specific marker selected from a protein, DNA, and RNA is analyzed, wherein the isolate was obtained by fractionating an ejaculate into a low-density cell population and a high-density cell population, wherein the high-density cell population comprising mature sperm cells was separated and the isolate comprises the low-density cell population, wherein the isolate comprises a cell pellet.
A use of an isolate from ejaculate, wherein the isolate comprises a cell pellet, wherein the isolate is obtained by fractionating ejaculate into a low-density cell population and a high-density cell population, wherein the high-density cell population, which comprises mature sperm cells, is separated and the isolate comprises the low-density cell population, for diagnosing and/or monitoring prostate cancer and/or for monitoring a success of therapy of prostate cancer.
Dependencies are inferred from the claim text.